Achalasia is a chronic, progressive condition that impairs the function of the lower oesophageal sphincter (LES)—the muscle that allows food to pass from the oesophagus into the stomach. When this muscle fails to relax properly, food and liquids become trapped in the oesophagus, leading to swallowing difficulties and other complications.
Although achalasia is considered rare, it has significant implications for quality of life. It can be misdiagnosed as gastroesophageal reflux disease (GERD) or other swallowing disorders. Early recognition and proper treatment are essential for effective management.
Achalasia is a motility disorder where the nerves in the oesophagus degenerate, particularly those that control the LES. As a result, the sphincter remains closed during swallowing, and the muscles in the oesophagus fail to contract normally.
The condition leads to symptoms like difficulty swallowing (dysphagia), regurgitation of food, chest pain, and weight loss. Achalasia is progressive and often worsens over time, requiring intervention for symptom relief.
In India, achalasia is underdiagnosed, but studies suggest an incidence of about 1.5 to 2 cases per 100,000 people per year. The condition is often identified late due to limited awareness and access to diagnostic facilities in some regions.
Globally, achalasia has an estimated prevalence of 10 to 15 cases per 100,000 individuals. It affects both genders equally and typically appears between the ages of 25 and 60.
Type II is the most common and typically responds best to treatment.
While the exact cause of achalasia remains unknown, several contributing factors include:
Secondary achalasia can occur due to conditions like Chagas disease or oesophageal cancer.
Symptoms may start subtly and progressively worsen, often prompting misdiagnosis.
Accurate diagnosis is critical to guide appropriate treatment and avoid complications.
There is no permanent cure, but treatments aim to relieve symptoms by relaxing or disrupting the LES.
Patients may require dietary adjustments or nutritional supplements in severe cases of malnutrition.
While alternative therapies do not replace medical treatment, supportive measures include:
Always consult a doctor before starting any complementary therapy.
If untreated, achalasia can lead to:
Regular follow-ups are essential to monitor for complications.
Dietary guidance and emotional support are vital aspects of long-term care.
Education helps patients understand and navigate their condition better.
Early intervention improves both symptom control and quality of life.
Small gestures of understanding can significantly ease the emotional burden.
Achalasia is a rare but impactful disease that requires a comprehensive treatment plan involving medications, dietary management, and in some cases, surgery. With proper care, patients can lead a relatively normal life. Increased awareness, early diagnosis, and effective support systems are key to improving outcomes.